BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Services

Samsung Biologics and Kineta Announce CDMO Agreement

Kineta to leverage Samsung Biologics' development and manufacturing expertise to advance KVA12.1 to IND Samsung Biologics San Francisco R&D cent...

July 21, 2021 | News

Frost & Sullivan recognizes leading global CRO Parexel

The company employs real-world data and evidence to accelerate research through targeted site and patient recruitment strategies Based on its rece...

July 20, 2021 | News

Novotech expands virtual clinical trials capabilities

The round was led by two new partners: Dedalus Group a leading healthcare and diagnostic software provider in Europe backed by Ardian, and Novotech H...

July 19, 2021 | News

Lonza Extends Collaboration with Major Biopharmaceutical Partner

Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain for the manufacture of an antibody-drug ...

July 17, 2021 | News

Merck and Universal Agree on the large-scale production of a new pediatric medication.

Merck has entered into a contract manufacturing agreement with Universal Corporation Ltd., Nairobi, Kenya, for the large-scale production of a new pediatri...

July 16, 2021 | News

Inotiv Acquires Genetic Toxicology Assets from Merck's BioReliance® portfolio

Robert Leasure, Jr., President and CEO of Inotiv, commented, “This transaction with MilliporeSigma adds genetic toxicology to our suite of internal c...

July 14, 2021 | News

Atossa Therapeutics Receives Approval To Open Clinical Study of AT-H201 in Australia

Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of signi...

July 08, 2021 | News

Toxicology IND Preclinical Research Services by Altogen Labs CRO

Pharmacology and toxicology testing performed both in vitro and in vivo, ensuring safety and effectiveness that is of utmost importance for any novel medic...

July 06, 2021 | News

Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs

Key Points GBM AGILE pivotal study of paxalisib is recruiting ahead of expectations, with almost 25 sites now open to the paxalisib arm. Paxalisib phas...

July 01, 2021 | News

Aragen Announces Expansion of Discovery Research Agreement with Boehringer Ingelheim

This preferred partnership allows Boehringer Ingelheim, a leading research driven pharmaceutical company, to incorporate several design elements, synthesiz...

June 30, 2021 | News

RedHill Biopharma's Opaganib Inhibits COVID-19 Variants in Preclinical Study

Opaganib's unique, orally-administered, host-targeted, dual antiviral and anti-inflammatory approach to combatting COVID-19 is also expected to maintain ef...

June 29, 2021 | News

Samsung Biologics continues to leverage remote audits and regulatory inspections

Samsung Biologics' Live Virtual Tour (LVT) used in one of the earliest FDA full virtual assessments Recently hosted EMA for 6 PAIs simultaneously using ...

June 24, 2021 | News

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...

June 23, 2021 | News

BIO to Hold First-Ever Clinical Trial Diversity Summit

The Biotechnology Innovation Organization (BIO) will hold its first-ever BIO Clinical Trial Diversity Summit June 24-25, 2021 to focus on th...

June 22, 2021 | News

Stay Connected